A Clinical Strain ofEscherichia coliPossessing CMY-2 Plasmid-Mediated Amp Cβ-Lactamase: An Emerging Concern in Pediatrics?

Abstract
A 5-year-old child was colonized by an isolate of Escherichia coli that transferred resistance to third-generation cephalosporins and cefoxitin. This resistance phenotype was encoded on a >75-kb plasmid pLRM 22. The transferable plasmid contained both blaCMY-2 and blaTEM-1b. Increasing reports of CMY-2 beta-lactamase in clinical isolates in children raise concerns about the empiric use of third-generation cephalosporins in this patient group.

This publication has 25 references indexed in Scilit: